Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
59 Years of MIKIWA Historical Perspective Brought Up-to-Date and an Invitation to CollaborateACS medicinal chemistry letters, 2024-04, Vol.15 (4), p.432-433 [Peer Reviewed Journal]Published 2024 by American Chemical Society ;ISSN: 1948-5875 ;EISSN: 1948-5875 ;DOI: 10.1021/acsmedchemlett.4c00108 ;PMID: 38628798Full text available |
|
2 |
Material Type: Article
|
Celebrating the 60th Anniversary of the MIKIW Meeting-in-Miniature: Virtual Special IssueACS medicinal chemistry letters, 2024-05, Vol.15 (5), p.565-566 [Peer Reviewed Journal]Published 2024 by American Chemical Society ;ISSN: 1948-5875 ;EISSN: 1948-5875 ;DOI: 10.1021/acsmedchemlett.4c00139 ;PMID: 38746893Full text available |
|
3 |
Material Type: Article
|
Structural Evaluations of a Selective Human STINGA230 Agonist and Its Use in Macrophage ImmunotherapiesACS medicinal chemistry letters, 2024-05, Vol.15 (5), p.653-658 [Peer Reviewed Journal]2024 American Chemical Society ;ISSN: 1948-5875 ;EISSN: 1948-5875 ;DOI: 10.1021/acsmedchemlett.4c00048Full text available |
|
4 |
Material Type: Article
|
Discovery of Sovleplenib, a Selective Inhibitor of Syk in Clinical Development for Autoimmune Diseases and CancersACS medicinal chemistry letters, 2024-05, Vol.15 (5), p.595-601 [Peer Reviewed Journal]2024 American Chemical Society ;2024 American Chemical Society. ;ISSN: 1948-5875 ;EISSN: 1948-5875 ;DOI: 10.1021/acsmedchemlett.3c00553 ;PMID: 38746892Full text available |
|
5 |
Material Type: Article
|
Novel Exatecan-Derived Topoisomerase‑1 Inhibitors for Treating CancerACS medicinal chemistry letters, 2024-05, Vol.15 (5), p.579-580 [Peer Reviewed Journal]Published 2024 by American Chemical Society ;Published 2024 by American Chemical Society. ;ISSN: 1948-5875 ;EISSN: 1948-5875 ;DOI: 10.1021/acsmedchemlett.4c00168 ;PMID: 38746899Full text available |
|
6 |
Material Type: Article
|
Transforming Therapeutic Approaches with PROTAC Technology: New Targets and PotentialsACS medicinal chemistry letters, 2024-05, Vol.15 (5), p.573-575 [Peer Reviewed Journal]Published 2024 by American Chemical Society ;Published 2024 by American Chemical Society. ;ISSN: 1948-5875 ;EISSN: 1948-5875 ;DOI: 10.1021/acsmedchemlett.4c00165 ;PMID: 38746888Full text available |
|
7 |
Material Type: Article
|
Novel Myeloperoxidase Inhibitors for Treating Multiple DiseasesACS medicinal chemistry letters, 2024-05, Vol.15 (5), p.569-570 [Peer Reviewed Journal]Published 2024 by American Chemical Society ;Published 2024 by American Chemical Society. ;ISSN: 1948-5875 ;EISSN: 1948-5875 ;DOI: 10.1021/acsmedchemlett.4c00133 ;PMID: 38746891Full text available |
|
8 |
Material Type: Article
|
Novel CD73 Inhibitors for Treating CancerACS medicinal chemistry letters, 2024-05, Vol.15 (5), p.571-572 [Peer Reviewed Journal]Published 2024 by American Chemical Society ;Published 2024 by American Chemical Society. ;ISSN: 1948-5875 ;EISSN: 1948-5875 ;DOI: 10.1021/acsmedchemlett.4c00137 ;PMID: 38746902Full text available |
|
9 |
Material Type: Article
|
Expanding TPD Horizons: Innovative Strategies Targeting BCL6 and SMARCA2ACS medicinal chemistry letters, 2024-05, Vol.15 (5), p.576-578 [Peer Reviewed Journal]Published 2024 by American Chemical Society ;Published 2024 by American Chemical Society. ;ISSN: 1948-5875 ;EISSN: 1948-5875 ;DOI: 10.1021/acsmedchemlett.4c00166 ;PMID: 38746879Full text available |
|
10 |
Material Type: Article
|
Pyrrolidinone Derivatives as NIK Inhibitors for Treating Autoimmune and Inflammatory DiseasesACS medicinal chemistry letters, 2024-05, Vol.15 (5), p.581-582 [Peer Reviewed Journal]Published 2024 by American Chemical Society ;Published 2024 by American Chemical Society. ;ISSN: 1948-5875 ;EISSN: 1948-5875 ;DOI: 10.1021/acsmedchemlett.4c00169 ;PMID: 38746901Full text available |
|
11 |
Material Type: Article
|
Novel ACC Inhibitors for Treating AcneACS medicinal chemistry letters, 2024-04, Vol.15 (4), p.445-446 [Peer Reviewed Journal]Published 2024 by American Chemical Society ;Published 2024 by American Chemical Society. ;ISSN: 1948-5875 ;EISSN: 1948-5875 ;DOI: 10.1021/acsmedchemlett.4c00118 ;PMID: 38628789Full text available |
|
12 |
Material Type: Article
|
Chemical Space Profiling of SARS-CoV‑2 PLpro Using DNA-Encoded Focused LibrariesACS medicinal chemistry letters, 2024-04, Vol.15 (4), p.555-564 [Peer Reviewed Journal]2024 American Chemical Society ;ISSN: 1948-5875 ;EISSN: 1948-5875 ;DOI: 10.1021/acsmedchemlett.4c00069Full text available |
|
13 |
Material Type: Article
|
Novel Isoxazolidines as RIPK1 Inhibitors for Treating Alzheimer’s Disease, Multiple Sclerosis, and Amyotrophic Lateral SclerosisACS medicinal chemistry letters, 2024-04, Vol.15 (4), p.447-448 [Peer Reviewed Journal]Published 2024 by American Chemical Society ;Published 2024 by American Chemical Society. ;ISSN: 1948-5875 ;EISSN: 1948-5875 ;DOI: 10.1021/acsmedchemlett.4c00119 ;PMID: 38628797Full text available |
|
14 |
Material Type: Article
|
Chemistry of Strigolactones, Key Players in Plant CommunicationChembiochem : a European journal of chemical biology, 2024-04 [Peer Reviewed Journal]Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1439-4227 ;EISSN: 1439-7633 ;DOI: 10.1002/cbic.202400133Digital Resources/Online E-Resources |
|
15 |
Material Type: Article
|
Quantum Tunneling in Natural Product BiosynthesisNatural product communications, 2024-04, Vol.19 (4) [Peer Reviewed Journal]The Author(s) 2024 ;ISSN: 1934-578X ;EISSN: 1555-9475 ;DOI: 10.1177/1934578X241240885Full text available |
|
16 |
Material Type: Article
|
Vinylpyridine as a Tunable Covalent Warhead Targeting C797 in EGFRACS medicinal chemistry letters, 2024-05, Vol.15 (5), p.583-589 [Peer Reviewed Journal]2024 American Chemical Society ;2024 American Chemical Society. ;ISSN: 1948-5875 ;EISSN: 1948-5875 ;DOI: 10.1021/acsmedchemlett.3c00425 ;PMID: 38746885Full text available |
|
17 |
Material Type: Article
|
Design, Synthesis, and Bioevaluation of Transcriptional Enhanced Assocciated Domain (TEAD) PROTAC DegradersACS medicinal chemistry letters, 2024-05, Vol.15 (5), p.631-639 [Peer Reviewed Journal]2024 American Chemical Society ;2024 American Chemical Society. ;ISSN: 1948-5875 ;EISSN: 1948-5875 ;DOI: 10.1021/acsmedchemlett.4c00029 ;PMID: 38746898Full text available |
|
18 |
Material Type: Article
|
Simple Fluorescence Labeling Method Enables Detection of Intracellular Distribution and Expression Level of Retinoid X ReceptorsACS medicinal chemistry letters, 2024-05, Vol.15 (5), p.640-645 [Peer Reviewed Journal]2024 American Chemical Society ;2024 American Chemical Society. ;ISSN: 1948-5875 ;EISSN: 1948-5875 ;DOI: 10.1021/acsmedchemlett.4c00033 ;PMID: 38746897Full text available |
|
19 |
Material Type: Article
|
Discovery of the First Potent DYRK2 Proteolysis Targeting Chimera DegradersACS medicinal chemistry letters, 2024-05, Vol.15 (5), p.659-666 [Peer Reviewed Journal]2024 American Chemical Society ;2024 American Chemical Society. ;ISSN: 1948-5875 ;EISSN: 1948-5875 ;DOI: 10.1021/acsmedchemlett.4c00065 ;PMID: 38746900Full text available |
|
20 |
Material Type: Article
|
A Tiny Pocket Packs a Punch: Leveraging Pyridones for the Discovery of CNS-Penetrant Aza-indazole IRAK4 InhibitorsACS medicinal chemistry letters, 2024-05, Vol.15 (5), p.714-721 [Peer Reviewed Journal]2024 American Chemical Society ;2024 American Chemical Society. ;ISSN: 1948-5875 ;EISSN: 1948-5875 ;DOI: 10.1021/acsmedchemlett.4c00102 ;PMID: 38746903Full text available |